FTC Tells DC Circ. To Undo Boehringer Doc Privilege Ruling
The Federal Trade Commission urged the D.C. Circuit on Monday to reverse a lower court's ruling that some financial documents subpoenaed in its Aggrenox pay-for-delay case against Boehringer Ingelheim Pharmaceuticals are...To view the full article, register now.
Already a subscriber? Click here to view full article